Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

REVB US Equity

Revelation Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1810560 · FY ends Dec 31
$1.11
+0.00 (+0.00%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-198-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ARMISTICE CAPITAL, LLCsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-138-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-07-138-K 3.03Material modification to rights of security holderssec.gov ↗
2026-07-138-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-13

Every row is a filed document, checked against its EDGAR index.